GLB1L3
Chr 11galactosidase beta 1 like 3
The GLB1L3 protein cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans. No definitive disease associations have been established for pathogenic variants in this gene based on the available data. The gene appears to tolerate loss-of-function variants well, as indicated by constraint metrics.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Tolerant to missense variation
ClinVar Variant Classifications
228 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 0 | 0 | 82 | 0 | 82 |
Likely Pathogenic | 0 | 0 | 7 | 0 | 7 |
VUS | 0 | 102 | 10 | 0 | 112 |
Likely Benign | 0 | 11 | 3 | 2 | 16 |
Benign | 0 | 0 | 2 | 0 | 2 |
| Total | 0 | 113 | 104 | 2 | 219 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
GLB1L3 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools